SOAT1 and neoplasm: Researchers have found that OXA could induce anti-tumor immunity, which produces anti-tumor immune effects by initiating ICD, acting on cellular STAT protein signaling pathway, and regulating the immunosuppression tumor microenvironment (Ghiringhelli et al., 2009; Hato et al., 2014).